SBI Securities’s Terns Pharmaceuticals TERN Stock Holding History

SBI Securities’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-372	Closed	-$19.6K	–	4183
2026 Q1	$19.6K	Buy	372 +170	+84%	+$6.98K	﹤0.01%	1470
2025 Q4	$8.16K	Buy	202 +77	+62%	+$1.78K	﹤0.01%	1806
2025 Q3	$939	Sell	125 -99	-44%	-$632	﹤0.01%	2717
2025 Q2	$836	Sell	224 -15	-6%	-$47	﹤0.01%	2759
2025 Q1	$660	Sell	239 -62	-21%	-$253	﹤0.01%	2757
2024 Q4	$1.67K	Buy	+301	New	+$2.04K	﹤0.01%	2377

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities's TERN Position: Q2 2026 in Review

SBI Securities sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 372 shares — an estimated $19.6K sold.

SBI Securities first reported a position in TERN in Q4 2024 and held it in 6 quarters. The position peaked at $19.6K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

SBI Securities reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 372 Terns Pharmaceuticals shares in Q2 2026, an estimated $19.6K.
SBI Securities first reported a position in Terns Pharmaceuticals in Q4 2024 and held it in 6 quarters.
SBI Securities's Terns Pharmaceuticals position peaked at $19.6K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.